That's a little over 13% of the 50m placement going to Macquarie.Not much for anyone else on Patterson's preferred list.I'd like to see the Top 20 list after all of this settles down.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
